Cigna Corp
NYSE:CI
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
265.59
366.85
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Cigna Corp
Cigna Corp
Current Portion of Long-Term Debt
Cigna Corp
Current Portion of Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Cigna Corp
NYSE:CI
|
Current Portion of Long-Term Debt
$937m
|
CAGR 3-Years
244%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
23%
|
|
|
DaVita Inc
NYSE:DVA
|
Current Portion of Long-Term Debt
$296.3m
|
CAGR 3-Years
21%
|
CAGR 5-Years
20%
|
CAGR 10-Years
9%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Current Portion of Long-Term Debt
$603m
|
CAGR 3-Years
745%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
39%
|
|
|
CVS Health Corp
NYSE:CVS
|
Current Portion of Long-Term Debt
$4.9B
|
CAGR 3-Years
47%
|
CAGR 5-Years
5%
|
CAGR 10-Years
24%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Current Portion of Long-Term Debt
$1.4B
|
CAGR 3-Years
387%
|
CAGR 5-Years
23%
|
CAGR 10-Years
31%
|
|
|
R1 RCM Inc
NASDAQ:RCM
|
Current Portion of Long-Term Debt
$72.8m
|
CAGR 3-Years
61%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Cigna Corp
Glance View
Cigna Corp., a stalwart in the healthcare sector, operates as a global health service company that skillfully navigates the intricacies of offering insurance and health-related products and services. Founded in 1982 from the merger of INA Corporation and Connecticut General Life Insurance Company, Cigna has entrenched itself as a key player in the industry. At its core, Cigna marries a robust understanding of healthcare with a sophisticated insurance model to address the diverse needs of individuals, employers, and governments. The company primarily generates revenue through insurance premiums, administrative service fees, and investment income. By providing an array of services, including medical, dental, and pharmacy benefits, as well as supplemental health and Medicare plans, Cigna captures a broad spectrum of the market, ensuring diversified revenue streams. The secret to Cigna’s enduring success lies in its commitment to innovation and integration within the healthcare space. By leveraging advanced technologies, Cigna enhances customer experiences and health outcomes, which, in turn, fortify its competitive edge. The company invests heavily in data analytics and personalized care, facilitating proactive health management that reduces costs and improves efficiency. Partnerships and collaborations with healthcare providers also play an instrumental role in controlling medical costs while maintaining quality care, underscoring its role as a pivotal intermediary between patients and providers. Through strategic acquisitions and expansions, such as its $67 billion acquisition of pharmacy benefit manager Express Scripts, Cigna continues to augment its service offerings, enabling synergies that amplify its reach and deepen its influence in the health services landscape.
See Also
What is Cigna Corp's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
937m
USD
Based on the financial report for Sep 30, 2024, Cigna Corp's Current Portion of Long-Term Debt amounts to 937m USD.
What is Cigna Corp's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 10Y
23%
Over the last year, the Current Portion of Long-Term Debt growth was -69%. The average annual Current Portion of Long-Term Debt growth rates for Cigna Corp have been 244% over the past three years , -23% over the past five years , and 23% over the past ten years .
You don't have any saved screeners yet